Methylphenidate and Pancreatic Enzyme Replacement Therapy
Commons · Question 44145 · Tabled 3 Apr 2025 · Department of Health and Social Care · Official record
Answered 9 Apr 2025
Question
Asked by Jess Brown-Fuller
To ask the Secretary of State for Health and Social Care, what progress he has made on increasing the availability of (a) methylphenidate and (b) pancreatic enzyme replacement therapy.
Answer
Answered by Karin Smyth, 9 Apr 2025
As a result of intensive work, some issues with attention deficit hyperactivity disorder medicines have resolved. All strengths of lisdexamfetamine, atomoxetine capsules, atomoxetine oral solution, and guanfacine prolonged-release tablets are now availabl...